XML 39 R21.htm IDEA: XBRL DOCUMENT v3.22.2
PROPERTY, PLANT AND EQUIPMENT
12 Months Ended
Mar. 31, 2022
Property, plant and equipment [abstract]  
PROPERTY, PLANT AND EQUIPMENT PROPERTY, PLANT AND EQUIPMENT
   MachineryAssets 
  
Buildings andunder 
 (amounts in millions)
and landSimulatorsequipmentAircraftconstructionTotal
Net book value as at March 31, 2020$262.8 $1,569.3 $51.4 $69.3 $201.2 $2,154.0 
Additions16.2 13.4 13.4 19.1 45.5 107.6 
Additions – business combinations (Note 3)0.3 7.9 0.3 — — 8.5 
Disposals— (1.9)(0.1)(0.4)(1.6)(4.0)
Depreciation(19.8)(113.3)(15.9)(5.8)— (154.8)
Impairment— (76.7)— — — (76.7)
Purchase of assets under lease (Note 15)
— 96.5 — — — 96.5 
Transfers and others36.1 48.8 1.4 0.6 (97.3)(10.4)
Foreign currency exchange differences(13.5)(120.9)(2.2)(6.7)(8.0)(151.3)
Net book value as at March 31, 2021$282.1 $1,423.1 $48.3 $76.1 $139.8 $1,969.4 
Additions29.4 14.5 15.5 1.6 211.2 272.2 
Additions – business combinations (Note 3)52.1 18.7 21.5 2.1 2.1 96.5 
Disposals(2.2)(0.4)(0.1)(1.1)— (3.8)
Depreciation(21.4)(101.1)(19.3)(5.2)— (147.0)
Impairment (13.8)(10.5)— — — (24.3)
Purchase of assets under lease (Note 15)
— 21.7 — — — 21.7 
Transfers and others1.1 97.6 1.1 (1.0)(95.5)3.3 
Foreign currency exchange differences(7.2)(48.5)(0.8)(1.0)(1.2)(58.7)
Net book value as at March 31, 2022$320.1 $1,415.1 $66.2 $71.5 $256.4 $2,129.3 
 
  MachineryAssets 
 Buildings andunder 
 (amounts in millions)
and landSimulatorsequipmentAircraftconstructionTotal
Cost$513.8 $2,140.6 $192.9 $91.9 $139.8 $3,079.0 
Accumulated depreciation and impairment(231.7)(717.5)(144.6)(15.8)— (1,109.6)
Net book value as at March 31, 2021$282.1 $1,423.1 $48.3 $76.1 $139.8 $1,969.4 
Cost$561.9 $2,180.7 $209.2 $89.4 $256.4 $3,297.6 
Accumulated depreciation and impairment(241.8)(765.6)(143.0)(17.9)— (1,168.3)
Net book value as at March 31, 2022$320.1 $1,415.1 $66.2 $71.5 $256.4 $2,129.3 
 
During the year ended March 31, 2022, depreciation of $145.0 million (2021 – $152.4 million) has been recorded in cost of sales, $0.5  million (2021 – $0.5 million) in research and development expenses and $1.5 million (2021 – $1.9 million) in selling, general and administrative expenses.